Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-2215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis ; volume:6 ; number:1 ; day:23 ; month:11 ; year:2013 ; pages:1-9 ; date:12.2013
Journal of ovarian research ; 6, Heft 1 (23.11.2013), 1-9, 12.2013
- Urheber
-
Lane, Denis
Matte, Isabelle
Laplante, Claude
Garde-Granger, Perrine
Rancourt, Claudine
Piché, Alain
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1757-2215-6-82
- URN
-
urn:nbn:de:101:1-2021081121455557174391
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 08:58 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lane, Denis
- Matte, Isabelle
- Laplante, Claude
- Garde-Granger, Perrine
- Rancourt, Claudine
- Piché, Alain
- SpringerLink (Online service)
Ähnliche Objekte (12)
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis
Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact
Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells
Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts
Modulation und funktionelle Relevanz des RANKL-TRAIL-Osteoprotegerin-Systems bei Mammakarzinomzellen
Modulation und funktionelle Relevanz des RANKL-TRAIL-Osteoprotegerin-Systems bei Mammakarzinomzellen
Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm
OPG Nachsortierung (Bestand)
Phosphoglycerate dehydrogenase activates PKM2 to phosphorylate histone H3T11 and attenuate cellular senescence
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis
Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact
Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells
Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts
Modulation und funktionelle Relevanz des RANKL-TRAIL-Osteoprotegerin-Systems bei Mammakarzinomzellen
Modulation und funktionelle Relevanz des RANKL-TRAIL-Osteoprotegerin-Systems bei Mammakarzinomzellen
Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm
OPG Nachsortierung (Bestand)
Phosphoglycerate dehydrogenase activates PKM2 to phosphorylate histone H3T11 and attenuate cellular senescence
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis
Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact
Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells
Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts
Modulation und funktionelle Relevanz des RANKL-TRAIL-Osteoprotegerin-Systems bei Mammakarzinomzellen
Modulation und funktionelle Relevanz des RANKL-TRAIL-Osteoprotegerin-Systems bei Mammakarzinomzellen
Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm
OPG Nachsortierung (Bestand)